European Pharmaceutical Review

JUNE 24, 2022

Following initial consultations in 2021, we expect the publication of the proposal for changes to the EU’s pharmaceutical legislation and potential adoption by the European Commission (EC) by December 2022. The actual legislation will then have a certain implementation period and will be prospective, for the most part. References.

Pharmaceutical 105

Pharmaceutical Medicine Marketing Competition 105

Pharmaceutical Technology

FEBRUARY 17, 2023

In 2021, the FDA granted Amgen’s (NASDAQ:AMGN) non-small cell lung cancer (NSCLC) drug Lumakras (sotorasib) an expedited approval, making it the first FDA-approved KRAS inhibitor. In 2021, Amgen agreed to conduct a Phase II study (NCT04933695), which is supposed to complete in May 2024, according to Clinicaltrials.gov.

FDA 115

FDA Side effects Pharmacology Patients 115

Clarify Health

FEBRUARY 8, 2022

2021 launched a new era for healthcare price transparency. In January 2021, the Healthcare Price Transparency Act went into effect, requiring hospitals to publish their cash pay rates and rates negotiated with health insurance companies.

Networking 52

Networking Marketing Competition Healthcare 52

pharmaphorum

NOVEMBER 21, 2022

Oxurion ended 2021 with €10 million in available cash, according to its annual report, and added to that total by raising another €10 million in a private placement that closed in March. That means it will have to raise additional funding or face the prospect of being unable to continue operations.

Prospecting 59

Prospecting Patients Competition FDA 59

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities. compared to a 5.1%

Medical 105

Medical Manufacturing Insurance Side effects 105

Pharmaceutical Technology

MAY 3, 2023

Gupta says that while 25 first generics were approved and launched in 2021, only by 23% of Medicare formularies covered them in that year. In 2017, FDA announced the Drug Competition Action Plan (DCAP) to allow consumers to get access to medicines. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Food and Drug Administration 98

Food and Drug Administration FDA Medicine Competition 98

Pharmaceutical Technology

NOVEMBER 30, 2022

The company’s weight loss drug Saxenda (liraglutide) won an approval for chronic weight management in December 2014, and Wegovy (semaglude) got the same tag in 2021. To overcome manufacturing issues, in December 2021, Novo Nordisk announced its plans to build three new manufacturing facilities. compared to a 5.1%

Medical 98

Medical Manufacturing Insurance Side effects 98

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

PM360

DECEMBER 20, 2023

It was the first $1bn quarter since 2021 which does suggest that biotech’s IPO window is opening once more. This allows for a complementary portfolio fit without the kind of competitive overlap that comes under regulatory scrutiny from the FTC. Demonstrate both and the path forwards becomes much clearer.

Biopharma 111

Biopharma Pharma Marketing Management 111

Pharmaceutical Technology

AUGUST 31, 2022

This forward-looking approach ranks Costa Rica as the top Latin American country in human capital, workforce skills and quality education, according to the WEF’s 2019 Global Competitiveness Report, and today its plethora of human talent is one of its key competitive differentiators for attracting foreign investors.

Education 52

Education Training Competition Manufacturing 52

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Although AbbVie will now face competition from these products, it has built a strong market for Humira, says Hlávka, adding that it will likely continue reporting significant revenues.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

MAY 22, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Biopharma 116

Biopharma Prospecting Competition Pharmaceutical 116

Pharmaceutical Technology

MAY 31, 2023

In January 2021, the US Food and Drug Administration (FDA) granted SNIPR001 a fast track designation. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. SNIPR plans to develop SNIPR001 for patients with hematological malignancies who are undergoing hematopoietic stem cell transplants.

Food and Drug Administration 98

Food and Drug Administration Safety Side effects FDA 98

Pharmaceutical Technology

JUNE 7, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Prospecting 105

Prospecting Patients Marketing Competition 105

The Marketing Advantage

JULY 13, 2021

July 13, 2021 A critical component of optimizing the sales force’s productivity and efficiency is ensuring HCP and/or account targets are being called on at the proper frequency. The right sales force calling on the right targets at the wrong frequency hinders the sales force’s selling efforts and ultimately leaves sales on the table.

Sales 52

Sales Prospecting Pharma Physicians 52

Pharmaceutical Technology

MAY 30, 2023

Launched back in 2021, AION Labs was formed as an alliance between AstraZeneca , Merck , Pfizer and Teva , as well as Amazon and the Israel Biotech Fund. 2021 was a year of continued innovation and change in the Biopharmaceutical industry. Free Report How is the Biopharmaceutical industry evolving?

Pharma 84

Pharma Government Prospecting Education 84

Pharmaceutical Technology

APRIL 26, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Marketing 102

Marketing Pharmaceutical Manufacturing Prospecting 102

Pharmaceutical Technology

APRIL 25, 2023

In October 2021, the World Health Organization recommended the use of GSK’s recombinant protein-based vaccine Mosquirix (RTS,S/AS01) for children at risk of contracting the infectious disease. From 2020 to 2021, cases of malaria increased from 245 million to 247 million in 84 malaria-endemic countries.

Food and Drug Administration 69

Food and Drug Administration Government Prospecting Food 69

Clarivate

DECEMBER 6, 2022

In a fiercely competitive U.S. While marquee IDNs attract national headlines, these smaller systems reflect how markets are adjusting to an increasingly value-based and competitive landscape. The two launched a joint-venture company in April 2021 designed to integrate their collective data to improve efficiencies and outcomes.

Networking 52

Networking Healthcare Healthcare Competition 52

Pharmaceutical Technology

JUNE 20, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Safety 98

Safety Patients Prospecting Marketing 98

Pharmaceutical Technology

MAY 3, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Food and Drug Administration 97

Food and Drug Administration FDA Patients Prospecting 97

Pharmaceutical Technology

APRIL 18, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

FDA 102

FDA Pharmaceutical Prospecting Patients 102

Pharmaceutical Representative Training

JANUARY 8, 2025

1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? link] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs? Pharma Sales Training. PRC Program Information. CNPR Pharmaceutical Sales Program.

Pharmacology 52

Pharmacology Pharma sales reps Sales Pharma 52

Spotio

FEBRUARY 9, 2023

Finally, they must convey all of this information to knowledgeable prospects, who will likely ask detailed questions. Adapting to an omnichannel sales process As of August 2021, only 58% of physicians want to meet with medical sales reps face-to-face. Increased competition Your sales team also faces more competition than ever before.

Sales 52

Sales Medical Doctors Sales process 52

Quantified

AUGUST 16, 2022

making it harder for them to get in front of their prospects than half a decade ago. On the same note, it can help you stay competitive, improve the customer experience, and ultimately win more business. Even with the return to normalcy in 2021 and 2022, the fortunes of digital sales continue to soar. What Is Sales Training?

Training 52

Training Sales Leads Retail 52

Pharmaceutical Technology

JANUARY 22, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

FDA 126

FDA Safety Pharmaceutical Patients 126

Pharmaceutical Technology

APRIL 11, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Medicine 98

Medicine Patients Safety Prospecting 98

Pharmaceutical Technology

JUNE 20, 2023

GlobalData is the parent company of Pharmaceutical Technology DICE’s novel oral therapeutic candidates positioned it as an attractive prospect for acquisition. It established an immunology business unit back in 2021 , supported by drugs like Omvoh (mirikizumab) for ulcerative colitis and lebrikizumab for atopic dermatitis.

Prospecting 52

Prospecting Competition Biopharma Marketing 52

Pharmaceutical Technology

APRIL 12, 2023

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

Manufacturing 93

Manufacturing Sales Government Prospecting 93

Pharmaceutical Technology

DECEMBER 7, 2022

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. How is the Biopharmaceutical industry evolving?

Patients 105

Patients Prospecting Competition Pharmaceutical 105

Integrity Solutions

MAY 24, 2023

If not, consider what steps you need to take to upgrade your sales training to be more effective, especially in light of today’s complex, competitive selling environment. In 2021, 40% of employees cited burnout as the top reason for leaving. Do they give customers line of sight to an optimum decision-making process?

Training 130

Training Sales Management Sales Management 130

Pharmaceutical Technology

APRIL 17, 2023

In December 2021, the US Food and Drug Administration (FDA) approved argenx’s Vyvgart for the treatment of myasthenia gravis in December 2021, marking the company’s first approval. The FDA approved Vyvgart for the treatment of myasthenia gravis in December 2021. Free Report How is the Biopharmaceutical industry evolving?

Engineering 52

Engineering Food and Drug Administration FDA Prospecting 52

European Pharmaceutical Review

DECEMBER 22, 2022

The success of the MCB choice impacts both regulatory approval prospects and the manufacturability of the bsAb. competitive binding-MS for analysis of multiple PQAs and rapid HT N-glycan analysis using combined LC/MS. 2021 Sep;99:102240. 2021 Jul;9(14):1144. Lim SM, Pyo KH, Soo RA, Cho BC. Cancer Treat Rev. 2021.102240.

Manufacturing 98

Manufacturing Leads Engineering Pharmaceutical 98

Pharmaceutical Technology

MAY 9, 2023

However, as donanemab’s approval prospects increase, it is an open question whether the drug’s prospects for Centers for Medicare & Medicaid Services (CMS) coverage are better than those of previously approved amyloid-targeting therapies. The FDA approved Biogen’s Aduhelm (aducanumab) for treating Alzheimer’s disease in June 2021.

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

MAY 9, 2023

However, as donanemab’s approval prospects increase, it is an open question whether the drug’s prospects for Centers for Medicare & Medicaid Services (CMS) coverage are better than those of previously approved amyloid-targeting therapies. The FDA approved Biogen’s Aduhelm (aducanumab) for treating Alzheimer’s disease in June 2021.

FDA 52

FDA Prospecting Patients Marketing 52

Pharmaceutical Technology

DECEMBER 7, 2022

2021 was a year of continued innovation and change in the Biopharmaceutical industry. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape. How is the Biopharmaceutical industry evolving?

Patients 98

Patients Prospecting Competition Pharmaceutical 98

Spotio

NOVEMBER 21, 2022

It’s no secret technology and the pandemic has transformed how businesses communicate with customers and prospects. Although sales reps will need to rework traditional sales strategies, it’s believed that it may be more effective in the long run by appealing to their prospects’ way of making decisions.

Sales 52

Sales B2B Sales Prospecting Sales process 52